OCGN
OCGN
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
3
$58K
Insider Sales
2
$1.09M
Total Volume
$1.15M
10 transactions
Net Activity
$1.03M
Net selling
Sentiment Rating
Neutral / BalancedCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 95% of total transaction value.
- •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
S - Sale Insiders
$12.92B total
Musunuri Shankar
CEO
$1.09M total
Johnson-Greene Treerita Essalima
CFO
$26K total
Castillo Kirsten
Dir
$23K total
Fernandes Prabhavathi
Dir
$9K total
Quick Actions
OCGN has an insider buy conviction of 5%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at OCGN (OCGN) engaged in a total of 10 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 2 were sales. The total volume of insider trading reached $1.15M.
The net insider activity for OCGN shows a net selling bias of $1.03M. This activity represents a 5% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 521.4K shares valued at $10.95B on Jun 15, 2026.
Ocugen (OCGN) Stock Draws Fresh Price Target Split After Cautious Analyst View
Is OCGN Stock Worth the Risk Ahead of 2026-27 Eye Gene Therapy Data?
Ocugen (NasdaqCM:OCGN) Stock Forecast & Analyst Predictions
OCGN - Ocugen Inc Stock Price and Quote
OCGN Stock Slides As Traders Focus On Cash Burn And Key Support
An officer proposes selling 525,991 Ocugen (OCGN) shares through Merrill Lynch.
FAQs About OCGN Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for OCGN.